Division of Molecular & Genomic PathologyThe Division of Molecular & Genomic Pathology (MGP) and MGP laboratory combine more than two decades of academic experience and leadership in molecular diagnostics to deliver the most advanced genomic testing and offer vast educational opportunities in molecular pathology. Our focus is on performing and interpreting complex genetic tests in the areas of solid tumors, hematologic malignancies, and genetics. Adopting and advancing the most innovative genomic technologies and working closely with the oncology and other clinical groups, our mission is to provide the laboratory support for the development and expansion of personalized medicine.
The current MGP Division and laboratory were formed in March 2013 by merging into one program the previously existing Molecular Anatomic Pathology and Molecular Diagnostics programs at the Department of Pathology, University of Pittsburgh Medical Center (UPMC). By integrating the resources and experience of the two nationally recognized molecular pathology programs, we are committed to providing the highest standards of education and clinical service for our physicians and patients.
News and Events
- Gene Technology a "revolution" in cancer fight: UPMC among 7 facilities in nation using advanced gene technology in cancer fight
- UPMC Expands the Use of Next-Generation Sequencing for Cancer Patients to Guide New Therapies
- “New Diagnostic Tool Ready for Prime Time in Thyroid Cancer”
- “New Cancer Test Could Save Patients From Diagnostic Surgeries”
- “Next-generation sequencing tool shows 96% specificity in thyroid cancer detection”
- “Next Generation Sequencing Test Developed at UPMC Improves Detection of Thyroid Cancer, Reduces Unnecessary Surgeries”